Pfizer supplies low-cost medicines to 45 low-income countries

Pfizer has announced that it will supply both current and future patent-protected drugs and vaccines to 45 low-income countries on a non-profit basis, and is discussing similar steps with other large pharmaceutical companies.

The New York-based pharmaceutical company announced its “Act for a Healthier World” at the World Economic Forum’s (WEF) annual meeting in Davos, committing to $1.2 billion in all its products sold in the U.S. and Europe. . We live in 27 low-income countries, including Afghanistan and Ethiopia, and 18 low-income countries, including Ghana.

Pfizer has previously been criticized for taking “pandemic gains” for making huge profits from COVID-19-related drugs over the past two years. The Covid-19 vaccine, developed in collaboration with Germany’s BioNTech, and a new Covid pill for people at high risk of severe disease, have generated nearly $15 billion in sales in just three months.

Pfizer CEO Albert Bourla said, “We live in an era where science is increasingly demonstrating our ability to combat some of the world’s deadliest diseases. “Unfortunately, there is a huge health equity gap in our world that determines which of us can and cannot use these innovations.”

He said this at a WEF meeting in Switzerland. “I am sure other pharmaceutical companies will follow. I spoke to some CEOs and they wanted to be part of them. So I hope to be able to get some medicine, but it won’t be enough. We also have to work in the field for diagnosis and treatment, which will require the help of WHO, Doctors Without Borders and many other organizations.”

The US pharmaceutical company is working closely with healthcare providers in Rwanda, Ghana, Malawi, Senegal and Uganda to support the diagnosis, education and training of doctors and nurses, and to improve infrastructure to ensure that all medicines and vaccines reach those in need. We provide the expertise to support you. Lessons learned in these five countries apply to rollouts to the other 40 countries.

“As we learned from the Covid vaccine launch, ensuring supply is only the first step in helping patients,” Bourla said. “To make the agreement a success, we look forward to working with global health leaders to make improvements in other aspects such as diagnostics, education, infrastructure, storage, logistics and more.”

Rwanda’s President Paul Kagame, who appeared with Bourla, said: Pfizer’s commitment to the agreement sets a new standard we want others to emulate.”

Malawi’s President, Lazarus Chakwera, said it is “a historic and unprecedented agreement” that brings together decision makers from government, the private sector and civil society. “Putting human development ahead of business interests and political attitudes is not a handout, it’s a genuine partnership,” he said.

Pfizer is working with the Bill & Melinda Gates Foundation to develop new products, such as vaccines, to prevent the deadly group B streptococci and respiratory syncytial virus, which can be serious in children and the elderly.

Sign up for our daily Business Today email or Twitter @BusinessDesk
Follow Guardian Business at

Also on the panel, Bill Gates said: We’ve seen it with Covid, but it’s not there.”

Microsoft’s co-founder told WEF: The tragedies of war extend far beyond the battlefield. The epidemic has been a setback, we are now causing more malaria deaths than three years ago, and the number of routine immunizations is significantly reduced.”

The billionaire and philanthropist said his dream was to create a powerful antimalarial vaccine because a vaccine funded by the Gates Foundation and developed by GSK is too short in terms of duration and protection.

Leave a Comment